Triple negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks expression of targetable receptors maintained by other subtypes of the disease, including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2). The gene discussed is ERBB2; the disease is breast carcinoma.